InVivo Therapeutics Holdings Corp. (NVIV) Reaches $9.40 After 6.00% Up Move; Fidus Investment (FDUS) Shorts Raised By 74.03%

April 17, 2018 - By Vivian Park

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Logo

Fidus Investment Corporation (NASDAQ:FDUS) had an increase of 74.03% in short interest. FDUS’s SI was 76,400 shares in April as released by FINRA. Its up 74.03% from 43,900 shares previously. With 137,600 avg volume, 1 days are for Fidus Investment Corporation (NASDAQ:FDUS)’s short sellers to cover FDUS’s short positions. The stock increased 0.08% or $0.01 during the last trading session, reaching $13.07. About 120,742 shares traded. Fidus Investment Corporation (NASDAQ:FDUS) has declined 23.54% since April 17, 2017 and is downtrending. It has underperformed by 35.09% the S&P500.

The stock of InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) is a huge mover today! The stock increased 13.08% or $1.09 during the last trading session, reaching $9.4. About 50,949 shares traded. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.02% since April 17, 2017 and is downtrending. It has underperformed by 98.57% the S&P500.The move comes after 5 months positive chart setup for the $357.71M company. It was reported on Apr, 17 by Barchart.com. We have $9.96 PT which if reached, will make NASDAQ:NVIV worth $21.46M more.

Investors sentiment decreased to 1.12 in 2017 Q4. Its down 0.28, from 1.4 in 2017Q3. It turned negative, as 8 investors sold Fidus Investment Corporation shares while 17 reduced holdings. 12 funds opened positions while 16 raised stakes. 7.12 million shares or 0.06% more from 7.12 million shares in 2017Q3 were reported. Citigroup Incorporated reported 0% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS). Baystate Wealth accumulated 1,500 shares or 0% of the stock. Salzhauer Michael has invested 0.12% in Fidus Investment Corporation (NASDAQ:FDUS). Pub Employees Retirement Of Ohio holds 0.01% or 107,000 shares in its portfolio. Morgan Stanley has invested 0% in Fidus Investment Corporation (NASDAQ:FDUS). Mckinley Mgmt Limited Com Delaware reported 0.07% stake. Moreover, Millennium Mgmt Limited Liability Corporation has 0% invested in Fidus Investment Corporation (NASDAQ:FDUS). Tudor Invest Corp Et Al, a Connecticut-based fund reported 10,731 shares. Wells Fargo & Company Mn owns 5,653 shares or 0% of their US portfolio. Legal General Gp Plc holds 0% of its portfolio in Fidus Investment Corporation (NASDAQ:FDUS) for 72,751 shares. Brown Brothers Harriman accumulated 11,828 shares. Kennedy Mgmt holds 250,221 shares or 0.07% of its portfolio. Raymond James & Associates reported 0.03% stake. The Illinois-based Optimum Inv has invested 0.12% in Fidus Investment Corporation (NASDAQ:FDUS). Raymond James Financial Advsrs Inc stated it has 493,399 shares.

Since March 7, 2018, it had 1 insider buy, and 0 insider sales for $91,700 activity. $91,700 worth of Fidus Investment Corporation (NASDAQ:FDUS) was bought by Sherard Shelby E.

Among 6 analysts covering Fidus Investment (NASDAQ:FDUS), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Fidus Investment had 10 analyst reports since January 15, 2016 according to SRatingsIntel. The rating was maintained by Oppenheimer on Friday, August 4 with “Buy”. The stock of Fidus Investment Corporation (NASDAQ:FDUS) has “Neutral” rating given on Monday, January 9 by Robert W. Baird. On Tuesday, January 10 the stock rating was initiated by Keefe Bruyette & Woods with “Mkt Perform”. The stock of Fidus Investment Corporation (NASDAQ:FDUS) has “Hold” rating given on Friday, November 3 by Robert W. Baird. As per Friday, January 15, the company rating was initiated by Janney Capital. Ladenburg initiated it with “Buy” rating and $15.0 target in Friday, February 16 report. The rating was maintained by Keefe Bruyette & Woods on Sunday, July 23 with “Hold”. The firm has “Hold” rating by Keefe Bruyette & Woods given on Wednesday, May 31. DA Davidson initiated Fidus Investment Corporation (NASDAQ:FDUS) rating on Friday, September 23. DA Davidson has “Buy” rating and $17 target. The rating was maintained by Keefe Bruyette & Woods on Sunday, October 22 with “Hold”.

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company has market cap of $357.71 million. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Therapeutic Trails injection program for the treatment of chronic SCI. It currently has negative earnings.

Fidus Investment Corporation (NASDAQ:FDUS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: